Cloud Data ServicesDigital WellnessHealth DiagnosticsHealth CareManufacturingPharmaceutical
Description
Galenica AG is a leading company in the healthcare sector that aims to enhance health and well-being across various platforms. The company's commitment to delivering integrated healthcare solutions is evident through its diversified services that spa…
Analysis
Middle-of-the-road
Galenica AG sits in the middle of our grid: average quality, average price, no obvious signal in either direction.
On valuation, the picture is fair. The owner-earnings multiple stands at 21.7×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 7% a year, against analyst forecasts of 8%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is adequate. The company scores 14/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.
360° rank · history
1007550250
Jan 202392
47
202320242026
All-time high
92
Jan 2023
All-time low
22
Jan 2024
Average rank
57
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
39
—
85
89
Price/Earnings
26
—
34
54
Price/Book
18
—
40
59
Dividend Yield
75
—
82
84
Value (overall)
21
—
65
82
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.